Trademark Overview
On Tuesday, July 2, 2024, a trademark application was filed for CHACM PEP with the United States Patent and Trademark Office. The USPTO has given the CHACM PEP trademark a serial number of 98630286. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, December 29, 2024. This trademark is owned by RJK Biopharma Inc.. The CHACM PEP trademark is filed in the Pharmaceutical Products category with the following description:
Biological preparations for the treatment of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Biological tissue cultures for medical purposes; Collyrium; Medicinal drinks; Amino acids for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Enzyme preparations for medical purposes; Dietetic foods adapted for medical purposes; All the above-mentioned goods relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration